News from valeant pharmaceuticals international, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 15, 2014, 16:30 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals To Hold Conference Call To Announce 2015 Financial Guidance

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet...

Nov 28, 2014, 17:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Announces Redemption of US$445.0 Million Aggregate Principal Amount of its Outstanding 6.875% Senior Notes due 2018

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that its wholly owned subsidiary, Valeant Pharmaceuticals...

Nov 25, 2014, 08:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals Announces FDA Approval Of ONEXTON™ Gel For The Treatment Of Acne Vulgaris

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that it has received approval from the Food and Drug...

Nov 20, 2014, 11:38 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals Announces New $2 Billion Securities Repurchase Program

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced today that its Board of Directors has authorized a new securities...

Nov 18, 2014, 08:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals And IDEAL IMPLANT Announce FDA And Health Canada Approval To Market Ideal Implant For Cosmetic Breast Augmentation

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and Ideal Implant Incorporated today announced the receipt of approval from...

Nov 17, 2014, 09:29 ET
Valeant Pharmaceuticals International, Inc.

Valeant Comments On Allergan Announcement

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) today commented on the announcement that Allergan, Inc. (NYSE: AGN) and Actavis plc...

Nov 13, 2014, 17:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals Completes Renovation Of U.S. Headquarters In New Jersey

Expansion of its U.S. headquarters solidifies commitment to grow jobs and support the local economy Valeant Pharmaceuticals International,...

Nov 07, 2014, 17:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals Sends Letter To Physician Customers

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today sent a letter to physician customers in order to address...

Nov 04, 2014, 13:27 ET
Valeant Pharmaceuticals International, Inc.

Valeant And Pershing Square May Vote At Special Meeting

 Today, the United States District Court for the Central District of California held that Pershing Square Capital Management, L.P., Valeant...

Oct 27, 2014, 06:55 ET
Valeant Pharmaceuticals International, Inc.

Valeant Delivers Letter To Allergan Board

· Prepared to Improve Offer And Provide Value of at Least $200 a Share · Urges Allergan Board to Take Control of Process...

Oct 20, 2014, 07:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals Reports Third Quarter 2014 Financial Results

  - 2014 Third Quarter Results - Total Revenue $2.1 billion; an increase of 33% over the prior year - Total same store sales...

Oct 15, 2014, 09:17 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals To Announce 2014 Third Quarter Results On October 20, 2014

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet webcast...

Sep 30, 2014, 11:27 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that the company's Bridgewater, New Jersey location received a...

Sep 26, 2014, 08:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Bausch + Lomb Announces Successful Results from Phase 3 Study of Sub-Micron Loteprednol Etabonate Ophthalmic Gel, 0.38%

Novel formulation, dosed twice daily, shows superiority to placebo (vehicle gel) in eliminating inflammation and pain following cataract surgery in...

Sep 25, 2014, 08:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Jeffrey W. Ubben, CEO Of ValueAct Capital, Appointed To The Board Of Valeant Pharmaceuticals

 Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) today announced that its Board of Directors has appointed Jeffrey W. Ubben,...

Sep 25, 2014, 02:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Bausch + Lomb and Nicox's Glaucoma Candidate VESNEO® (latanoprostene bunod) Meets Primary Endpoint in Phase 3 Studies

Expect to file in the U.S. in First Half of Q2 2015 Expect to launch in the U.S. in First Half of 2016 Peak U.S. sales ~$500 million+, Peak...

Sep 24, 2014, 09:05 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Provides Update On Third Quarter Results And Sends Letter To Allergan CEO And Lead Independent Director

Overall Same Store Organic Growth (unadjusted for generics) Expected to Exceed 15% in Third Quarter Bausch + Lomb Expected to Continue to Deliver...

Sep 15, 2014, 17:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Announces Redemption of All of the Outstanding $500.0 Million Aggregate Principal Amount of its 6.75% Senior Notes due 2017

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX:VRX) today announced that its wholly owned subsidiary, Valeant Pharmaceuticals...

Sep 08, 2014, 17:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Pharmaceuticals Expands Bausch + Lomb Manufacturing Facility, Adding 120 New Jobs in Rochester

Hosted Ribbon Cutting Ceremony for the New Bausch + Lomb ULTRA® Contact Lens Manufacturing Line and Solar Array Implementation...

Aug 15, 2014, 17:00 ET
Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.)

Valeant Extends Offer To Acquire Allergan

 Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) today announced that it has extended the expiration of its exchange offer to...